
Alumis Inc.
ALMSNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $810.87M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.37$31.35
- Volume (live)
- -
- Avg. volume (3M)
- 2.92M
Alumis (ALMS) Stock Price & Financial Analysis
Alumis Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.01 - $6.31 |
|---|---|
| 52-Week High | $31.35 |
| 52-Week Low | $4.37 |
| Open | $6.31 |
| Volume (last close) | 2.50M |
| Average Volume (3M) | 2.92M |
| Revenue (TTM) | 7.40M |
|---|---|
| Net Income (TTM) | -438.96M |
| Free Cash Flow (TTM) | -351.80M |
| EPS (TTM) | −$3.80 |
| Profit Margin | -5933.45% |
| Operating Margin | -5639.05% |
| Return on Equity (ROE) | -97.08% |
| Debt to Equity | 0.08 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 810.87M |
|---|---|
| Shares Outstanding | 128.51M |
| Price to Sales (P/S) | 109.61 |
| Price to Book (P/B) | 1.79 |
| EV/EBITDA | -1.94 |
| 50-Day MA | $14.42 |
|---|---|
| 200-Day MA | $21.95 |
| 1-Year Change | +40.53% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Alumis at a Glance
As of the Oct 16, 2026 close, Alumis (ALMS) has a market capitalization of $810.87M. The stock trades at 109.6× sales. Over the trailing twelve months it lost $438.96M on revenue of $7.40M and burned $351.80M of free cash flow. Revenue fell 63.1% year over year.
As of its latest reported balance sheet, it holds $63.71M in cash and securities against $36.43M of debt, a net cash position of $27.28M.
Alumis does not currently pay a dividend.
The share price is up 40.5% over the past year. At $6.12 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $4.37 to $31.35, below its 200-day moving average of $21.95.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $29.50, 382.0% above the Oct 16, 2026 close.
Frequently Asked Questions About Alumis
What is the current stock price for ALMS?
As of the Oct 16, 2026 close, ALMS stock trades at $6.12. The 52-week range is $4.37–$31.35, with a day range of $6.01–$6.31.
What is the P/E ratio for ALMS?
The P/E ratio (Price-to-Earnings) for ALMS is shown in the Key Statistics section. This valuation metric helps compare Alumis Inc. to industry peers.
Does ALMS pay dividends?
Alumis does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ALMS?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for ALMS is Buy. The average 12-month price target is $29.50, a 382.0% upside from the Oct 16, 2026 close of $6.12.
What is the market cap of ALMS?
As of the Oct 16, 2026 close, Alumis's market capitalization is $786.5M, classifying it as a small-cap company. Alumis operates in the Healthcare sector within the Biotechnology industry.